stockrowImunon, Inc. (IMNN) vs Niki BioSolutions, Inc. (NIKI)
- Imunon, Inc. IMNN 0.85 −5.56%
- Niki BioSolutions, Inc. NIKI 1.60 +6.67%
Imunon, Inc. and Niki BioSolutions, Inc. are both Biotechnology companies. Imunon, Inc. and Niki BioSolutions, Inc. are of similar size ($5.1M and $4.7M). Niki BioSolutions, Inc. grew revenue faster over the last twelve months: 42.6% against 0.00%. Imunon, Inc. has the higher net margin (0.00% vs −921.7%) and the lower return on invested capital (−324.4% vs 0.00%). Across the 14 metrics below, Niki BioSolutions, Inc. leads on 11 and Imunon, Inc. on 3.
Valuation
Profitability
| Metric | IMNN | NIKI | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | (87.96%) | 68.51% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | (921.74%) | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (641.02%) | 0.00% | (51.96%) |
| Return on assets | (123.93%) | 0.00% | (46.06%) |
| Return on invested capital | (324.37%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack